Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and ... Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Show more
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO, July 18, 2024 SAN DIEGO, July 18, 2024 /PRNewswire/ -- AsΒ Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24, the...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO, July 11, 2024 SAN DIEGO, July 11, 2024 /PRNewswire/ --Β As Illumina, Inc. (NASDAQ:ILMN...
Costco Wholesale (NASDAQ:COST) – Costco has increased its membership fees by $5 for annual members, while the top-tier plan sees a $10 increase. This is the first fee hike since 2017...
Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base PR Newswire SAN DIEGO, July 9, 2024 Β Accessible, highly scalable single-cell...
Nike (NYSE:NKE) – Nike shares fell 14.04% in pre-market trading. Nike exceeded fourth-quarter fiscal earnings estimates with adjusted earnings of $1.01 per share, but sales of $12.6 billion...
SolarEdge Technologies (NASDAQ:SEDG) – SolarEdge Technologies faces a 13.1% drop in pre-market trading after announcing the issuance of $300 million in senior convertible notes due 2029 and...
Illumina completes the divestiture of GRAIL PR Newswire SAN DIEGO, June 24, 2024 GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25Illumina to issue second quarter...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.5 | 1.29187839118 | 116.11 | 126.29 | 113.32 | 1772415 | 119.35154147 | CS |
4 | 8.21 | 7.50457038391 | 109.4 | 126.29 | 103.57 | 2124552 | 111.5412325 | CS |
12 | -6.05 | -4.89244703219 | 123.66 | 127.745 | 100.085 | 2775200 | 110.34626546 | CS |
26 | -19.41 | -14.1658152095 | 137.02 | 148.19 | 100.085 | 2152838 | 120.46713036 | CS |
52 | -72.47 | -38.1260521886 | 190.08 | 195.64 | 89 | 2139392 | 124.99852333 | CS |
156 | -364.62 | -75.6112228605 | 482.23 | 526 | 89 | 1531440 | 196.61494131 | CS |
260 | -176.95 | -60.0726507333 | 294.56 | 555.77 | 89 | 1352928 | 242.3638658 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.